These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 29752277)
81. Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status. Pappa KI; Choleza M; Markaki S; Giannikaki E; Kyroudi A; Vlachos G; Voulgaris Z; Anagnou NP Gynecol Oncol; 2006 Mar; 100(3):596-600. PubMed ID: 16256179 [TBL] [Abstract][Full Text] [Related]
82. Integrated Epigenomics Analysis Reveals a DNA Methylation Panel for Endometrial Cancer Detection Using Cervical Scrapings. Huang RL; Su PH; Liao YP; Wu TI; Hsu YT; Lin WY; Wang HC; Weng YC; Ou YC; Huang TH; Lai HC Clin Cancer Res; 2017 Jan; 23(1):263-272. PubMed ID: 27507616 [TBL] [Abstract][Full Text] [Related]
83. Establishment and characterization of a new lung cancer cell line (MI-4) producing high levels of granulocyte colony stimulating factor. Harada R; Uemura Y; Kobayashi M; Zamecnikova A; Nakata H; Taguchi T; Furihata M; Otsuki Y; Taguchi H Jpn J Cancer Res; 2002 Jun; 93(6):667-76. PubMed ID: 12079515 [TBL] [Abstract][Full Text] [Related]
84. Prognostic Factors for Endometrial and Cervical Cancers of Uterus Treated With Immune-cell Therapy: A Retrospective Study. Takimoto R; Kamigaki T; Okada S; Ibe H; Oguma E; Naitoh K; Makita K; Yasumoto K; Goto S Anticancer Res; 2020 Aug; 40(8):4729-4740. PubMed ID: 32727799 [TBL] [Abstract][Full Text] [Related]
85. MiR-200b promotes the cell proliferation and metastasis of cervical cancer by inhibiting FOXG1. Zeng F; Xue M; Xiao T; Li Y; Xiao S; Jiang B; Ren C Biomed Pharmacother; 2016 Apr; 79():294-301. PubMed ID: 27044840 [TBL] [Abstract][Full Text] [Related]
86. Impact of endostatin gene therapy on myeloid-derived suppressor cells from a metastatic renal cell carcinoma. Chaves KC; Costa EM; Teixeira LF; Bellini MH Exp Oncol; 2018 Mar; 40(1):24-32. PubMed ID: 29600976 [TBL] [Abstract][Full Text] [Related]
87. MDSCs: The Key Players in the Formation of Pre-Metastatic Niche. Cui W; Wang Z; Lv J; Qin Y; Shi H Front Biosci (Landmark Ed); 2023 Mar; 28(3):58. PubMed ID: 37005751 [TBL] [Abstract][Full Text] [Related]
88. Carving out its niche: A role for carbonic anhydrase IX in pre-metastatic niche development. Chafe SC; Dedhar S Oncoimmunology; 2015 Dec; 4(12):e1048955. PubMed ID: 26587316 [TBL] [Abstract][Full Text] [Related]
89. Metformin and Docosahexaenoic Acid Hybrid Micelles for Premetastatic Niche Modulation and Tumor Metastasis Suppression. Jiang T; Chen L; Huang Y; Wang J; Xu M; Zhou S; Gu X; Chen Y; Liang K; Pei Y; Song Q; Liu S; Ma F; Lu H; Gao X; Chen J Nano Lett; 2019 Jun; 19(6):3548-3562. PubMed ID: 31026397 [TBL] [Abstract][Full Text] [Related]
90. Pericytes in the Premetastatic Niche. Paiva AE; Lousado L; Guerra DAP; Azevedo PO; Sena IFG; Andreotti JP; Santos GSP; Gonçalves R; Mintz A; Birbrair A Cancer Res; 2018 Jun; 78(11):2779-2786. PubMed ID: 29789421 [TBL] [Abstract][Full Text] [Related]
91. Estrogen stimulates female cancer progression by inducing myeloid-derived suppressive cells: investigations on pregnant and non-pregnant experimental models. Kozasa K; Mabuchi S; Matsumoto Y; Kuroda H; Yokoi E; Komura N; Kawano M; Takahashi R; Sasano T; Shimura K; Kodama M; Hashimoto K; Sawada K; Nagasaka K; Kimura T Oncotarget; 2019 Mar; 10(20):1887-1902. PubMed ID: 30956772 [TBL] [Abstract][Full Text] [Related]
92. Tumor microenvironment promotes lymphatic metastasis of cervical cancer: its mechanisms and clinical implications. Li Y; Gao X; Huang Y; Zhu X; Chen Y; Xue L; Zhu Q; Wang B; Wu M Front Oncol; 2023; 13():1114042. PubMed ID: 37234990 [TBL] [Abstract][Full Text] [Related]
93. Endometrial cancer: experimental models useful for studies on molecular aspects of endometrial cancer and carcinogenesis. Vollmer G Endocr Relat Cancer; 2003 Mar; 10(1):23-42. PubMed ID: 12653669 [TBL] [Abstract][Full Text] [Related]
94. Characterization of metastasis formation and virotherapy in the human C33A cervical cancer model. Donat U; Rother J; Schäfer S; Hess M; Härtl B; Kober C; Langbein-Laugwitz J; Stritzker J; Chen NG; Aguilar RJ; Weibel S; Szalay AA PLoS One; 2014; 9(6):e98533. PubMed ID: 24887184 [TBL] [Abstract][Full Text] [Related]
95. Inhibitory Effect of Shen M; Wang YJ; Liu ZH; Chen YW; Liang QK; Li Y; Ming HX Evid Based Complement Alternat Med; 2023; 2023():4010797. PubMed ID: 36714534 [TBL] [Abstract][Full Text] [Related]
96. Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case Report. Madeddu C; Sanna E; Nemolato S; Mulas O; Oppi S; Scartozzi M; La Nasa G; Maccio A Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010260 [TBL] [Abstract][Full Text] [Related]
98. How to Target Spinal Metastasis in Experimental Research: An Overview of Currently Used Experimental Mouse Models and Future Prospects. Jelgersma C; Vajkoczy P Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34063821 [TBL] [Abstract][Full Text] [Related]
99. Role of myeloid-derived suppressor cells in the formation of pre-metastatic niche. Ya G; Ren W; Qin R; He J; Zhao S Front Oncol; 2022; 12():975261. PubMed ID: 36237333 [TBL] [Abstract][Full Text] [Related]
100. Moving Forward in Cervical Cancer: Enhancing Susceptibility to DNA Repair Inhibition and Damage, an NCI Clinical Trials Planning Meeting Report. Harkenrider MM; Markham MJ; Dizon DS; Jhingran A; Salani R; Serour RK; Lynn J; Kohn EC J Natl Cancer Inst; 2020 Nov; 112(11):1081-1088. PubMed ID: 32219419 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]